Methotrexat-Polyglutamate als Marker fuer das klinische Outcome in der Therapie der rheumatoiden Arthritis
- Conditions
- Rheumatoid Arthritis
- Registration Number
- EUCTR2007-006288-56-AT
- Lead Sponsor
- udwig Boltzmann Cluster für Rheumatologie, Balneologie und Rehabilitation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Informed consent, age > 18 years, MTX naive patients, X-ray, exclusion of pregnancy, DAS-28 > 3,2, contraception
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
age < 18 years, pregnant or nursing women, malignant diseases (last 5 years), prednisolon > 10 mg a day, alcohol abuse, low renal function, elevation of transaminases
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method